| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Sep―28 |
Development and Implementation of a Comprehensive Initiative to Educate Healthcare Providers and Patients in the United States about the Risk of Drug-Drug Interactions Associated with Nirmatrelvir/ritonavir during the COVID-19 Pandemic |
Iqra Arham, Donna Palumbo, Bharat Damle, Gurinder Sidhu, Domenick Francis, Alejandro Cané, Lubna Merchant, Jamie Wilkins, Reema Mehta, Amanda Radola, Karen Baker, Shoaib Khan, Vicky Hendrick, Aysha K Ali, Florin Draica |
| 2 |
[GO] |
2023―Feb―21 |
The Landscape of Neutralizing Monoclonal Antibodies (nAbs) for Treatment and Prevention of COVID-19 |
Aline de Almeida Oliveira, Diana Praia Borges Freire, Ana Rodrigues de Andrade, Amanda de Miranda Marques, Luciana da Silva Madeira, José Procópio Moreno Senna, Ivna Alana Freitas Brasileiro da Silveira, Beatriz de Castro Fialho |
| 3 |
[GO] |
2023―Feb―13 |
Vaccine Innovation Meta-Model for Pandemic Contexts |
Beatriz C. Fialho, Leandro Gauss, Priscila F. Soares, Maurício Z. Medeiros, Daniel P. Lacerda |
| 4 |
[GO] |
2021―Feb―02 |
Analysis of the COVID-19 Vaccine Development Process: an Exploratory Study of Accelerating Factors and Innovative Environments |
Hugo Garcia Tonioli Defendi, Luciana da Silva Madeira, Suzana Borschiver |
| 5 |
[GO] |
2020―Aug―13 |
Editorial: Despite COVID-19, Pharmaceutical Innovation Marches On! |
Stephen Scypinski |
|
